z-logo
open-access-imgOpen Access
Cardiovascular complications in COVID‐19 patients with or without diabetes mellitus
Author(s) -
Abe Temidayo,
Egbuche Obiora,
Igwe Joseph,
Jegede Opeyemi,
Wagle Bivek,
Olanipekun Titilope,
Onwuanyi Anekwe
Publication year - 2021
Publication title -
endocrinology, diabetes and metabolism
Language(s) - English
Resource type - Journals
ISSN - 2398-9238
DOI - 10.1002/edm2.218
Subject(s) - medicine , atrial fibrillation , heart failure , diabetes mellitus , cardiology , myocardial infarction , odds ratio , confounding , logistic regression , myocarditis , endocrinology
Coronavirus disease 2019 (COVID‐19) has become a major global crisis. Preliminary reports have, in general, indicated worse outcomes in diabetes mellitus (DM) patients, but the magnitude of cardiovascular (CV) complications in this subgroup has not been elucidated. Methods We included 142 patients admitted with laboratory‐confirmed COVID‐19 from April 1st to May 30th 2020; 71 (50%) had DM. We compared baseline demographics and study outcomes between those with or without DM using descriptive statistics. Multivariate logistic regression was used to estimate the adjusted odds ratio for the study outcomes in DM patients, compared to those without DM, stratified by age, sex and glycaemic control. CV outcomes of interest include acute myocarditis, acute heart failure, acute myocardial infarction, new‐onset atrial fibrillation and composite cardiovascular end‐point consisting of all individual outcomes above. Result Mean age was 58 years. The unadjusted rates were higher in DM patients compared to non‐diabetics for the composite cardiovascular end‐point (73.2% vs. 40.6% p  < .0001), acute myocarditis (36.6% vs. 15.5% p  = .004), acute heart failure (25.3% vs. 5.6% p  = .001), acute myocardial infarction (9.9% vs. 1.4% p  = .03) and new‐onset atrial fibrillation (12.7% vs. 1.4% p  = .009). After controlling for relevant confounding variables, diabetic patients had higher odds of composite cardiovascular end‐point, acute heart failure and new‐onset atrial fibrillation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here